Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...

following tamoxifen for 2–3 years (early 'switch' treatment) or 5 years (extended adjuvant treatment). Reducing recurrence risk is a primary goal of adjuvant hormonal therapy. There is an early ...

Nat Clin Pract Oncol. 2008;5(9):531-542. The authors declared no competing interests. Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co ...

Every patient received treatments such as tamoxifen or aromatase inhibitors ... Recent research has suggested that extending hormone therapy to 10 years may be more effective at preventing breast ...

and several studies have indicated that aromatase inhibitors cause less toxicity and fewer side effects than Tamoxifen. "In terms of hormonal therapies, we now have a significant number of agents ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now ... with estrogen-suppressing drugs, often tamoxifen. However, anti-hormonal treatment reduces ...

The therapies that protect you from recurrence—life-saving treatments like tamoxifen and aromatase ... For many, the side effects of hormone therapy—crippling anxiety, sexual dysfunction ...

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

These include chemotherapy and endocrine (hormone) therapy such as tamoxifen. Such treatments cause suppression of ovarian function. In post-menopausal women, the use of other hormonal drugs—eg, ...

Oncology drugs help in the prevention, diagnosis, and treatment of cancer. It includes chemotherapy drugs, hormone therapy drugs such as Tamoxifen (brand name ...

ER earmarks a primary breast tumor for an initially positive prognosis and the probability of a good response to hormone ablation therapy ... tumors selected for tamoxifen treatment, roughly ...